Clinical pharmacological study of TTS-NTG in healthy volunteers. II. 48 Hours application.:48 Hours Application
スポンサーリンク
概要
- 論文の詳細を見る
A transdermal. therapeutic system (TTS) containing nitroglycerin (NTG) was applied to 12 healthy male volunteers for 24 hours and 48 hours.<BR>Plasma NTG concentration was measured by capillary gas chromatography with electron capture detection using butane-1, 2, 4-triol-trinitrate as the internal standard.<BR>The mean plasma concentration over the intervals of 1-24 hours and 1-48 hours after application maintained a steady level throughout the application. The mean plasma level in the steady-state phase for the 48-hour application was similar to that for 24 hours.<BR>The notable subjective symptoms of TTS-NTG were generally reported as headache and/or heaviness of the head, but in the 48-hour application study, the incidence and intensity of these symptoms were reduced on the second day.<BR>The local irritation was well acceptable. Several subjects showed mild rubef action at the margin of the covered area of skin, but there was no difference between the 24-hour and 48-hour applications in the local irritation index.<BR>The residual amount of used system was analyzed by HPLC. The release rate of the system was 15.8±1.19μg/cm<SUP>2</SUP>·h (mean±S. E.) for the 24-hour, and 14.9±0.79μg/cm<SUP>2</SUP>·h (mean±S.E.) for the 48-hour application.
- 一般社団法人 日本臨床薬理学会の論文
著者
関連論文
- 経皮吸収製剤 (TTS) における放出制御膜
- Phase I Study of CT-848 (The 1st Report). The Study in Single Oral Administration.:The Study in Single Oral Administration
- Phase I Study of CT-848 (The 2nd Report). The Study in Multiple Oral Administration.:The Study in Multiple Oral Administration
- Clinical pharmacological study of TTS-NTG in healthy volunteers. II. 48 Hours application.:48 Hours Application